Workflow
协定性存款
icon
Search documents
益方生物拟用不超10亿元闲置募集资金进行现金管理
Xin Lang Cai Jing· 2025-08-23 05:28
登录新浪财经APP 搜索【信披】查看更多考评等级 益方生物科技(上海)股份有限公司(证券代码:688382)于2025年8月21日召开第二届董事会2025年 第五次会议,审议通过《关于使用部分闲置募集资金进行现金管理的议案》,同意公司使用不超过人民 币10亿元(包含本数)的暂时闲置募集资金进行现金管理。 募集资金基本情况 声明:市场有风险,投资需谨慎。 本文为AI大模型基于第三方数据库自动发布,任何在本文出现的信 息(包括但不限于个股、评论、预测、图表、指标、理论、任何形式的表述等)均只作为参考,不构成 个人投资建议。受限于第三方数据库质量等问题,我们无法对数据的真实性及完整性进行分辨或核验, 因此本文内容可能出现不准确、不完整、误导性的内容或信息,具体以公司公告为准。如有疑问,请联 系biz@staff.sina.com.cn。 责任编辑:小浪快报 审议程序与风险控制 会议审议通过使用部分闲置募集资金进行现金管理的议案,闲置资金现金管理产品到期后,募集资金将 归还至专户或于产品专用结算账户续存。尽管选择低风险产品,但投资仍可能受市场波动影响。为此, 公司建立健全审批和执行程序,采取多项风险控制措施,包括通过 ...
中船特气: 中信建投证券股份有限公司关于中船(邯郸)派瑞特种气体股份有限公司使用暂时闲置募集资金和自有资金进行现金管理的核查意见
Zheng Quan Zhi Xing· 2025-08-22 16:24
中信建投证券股份有限公司 关于中船(邯郸)派瑞特种气体股份有限公司 一、募集资金基本情况 根据中国证券监督管理委员会出具的《关于同意中船(邯郸)派瑞特种气体 股份有限公司首次公开发行股票注册的批复》(证监许可(2023)420 号)的同 意,公司首次向社会公开发行人民币普通股(A 股)股票 79,411,765 股,每股发 行价格人民币 36.15 元,募集资金总额为人民币 2,870,735,304.75 元,扣除发行 费用人民币 68,004,839.72 元(不含税金额),公司本次募集资金净额为人民币 日对上述资金的到位情况进行了审验,并出具了信会师报字[2023]第 ZG11051 号 验资报告。 为规范公司募集资金管理和使用,保护投资者权益,公司设立了相关募集资 金专用账户。募集资金到账后,公司对募集资金进行了专户存储,并与保荐机构、 存放募集资金的银行签署了募集资金专户存储监管协议。 二、募集资金投资项目情况 使用暂时闲置募集资金和自有资金进行现金管理 的核查意见 中信建投证券股份有限公司(以下简称"中信建投证券" "保荐机构")作为 中船(邯郸)派瑞特种气体股份有限公司(以下简称"中船特气" " ...
奥浦迈: 奥浦迈:关于使用部分闲置募集资金进行现金管理的公告
Zheng Quan Zhi Xing· 2025-08-22 14:17
Summary of Key Points Core Viewpoint - The company, Shanghai Aopumai Biotechnology Co., Ltd., plans to utilize part of its idle raised funds for cash management, with a maximum investment amount of RMB 700 million, ensuring high safety and liquidity in the investment products chosen [1][2][8]. Investment Overview - **Investment Purpose**: The aim is to maximize shareholder value by improving the efficiency of fund usage while ensuring that the use of raised funds is not affected and risks are effectively controlled [2][6]. - **Investment Amount and Duration**: The company intends to use up to RMB 700 million for cash management, with the funds being able to roll over within a 12-month period [2][5]. - **Source of Funds**: The funds are sourced from the proceeds of the company's initial public offering, which raised a total of approximately RMB 1.64 billion after deducting issuance costs [2][5]. Investment Methodology - The company will invest in high-safety, liquid financial products such as agreement deposits, structured deposits, time deposits, notice deposits, large certificates of deposit, and income certificates [1][5][6]. - The cash management products will not be used for pledging or for investment purposes in securities [5][6]. Approval Process - The board of directors and the supervisory board approved the cash management proposal during meetings held on August 21, 2025, with a validity period of 12 months from the date of approval [2][6][8]. - The management team has been authorized to make investment decisions and sign relevant contracts, with the finance department responsible for implementation [1][6]. Opinions from Supervisory Board and Sponsor - The supervisory board supports the cash management initiative, stating it will not affect the use of raised funds or harm the interests of the company and its shareholders [7][8]. - The sponsor, Guotai Junan Securities, has confirmed that the cash management plan complies with relevant regulations and will enhance fund usage efficiency without altering the intended use of raised funds [8].
上海丛麟环保科技股份有限公司关于使用部分暂时闲置募集资金进行现金管理的公告
Core Viewpoint - The company plans to use up to RMB 600 million of temporarily idle raised funds for cash management, focusing on high-security and liquid investment products, without affecting the normal operation of fundraising projects [2][3][12]. Group 1: Cash Management Overview - The purpose of cash management is to enhance the efficiency of fund usage and increase company revenue while ensuring that it does not impact the construction of fundraising projects [3]. - The decision allows for a maximum of RMB 600 million to be used for cash management, with a validity period of 12 months from the board's approval [4][12]. - The funds will be used to purchase safe and liquid financial products, including but not limited to structured deposits and large certificates of deposit, with a maximum investment period of 12 months [8]. Group 2: Fund Source and Investment Projects - The company raised a total of RMB 1.589 billion from its initial public offering, with a net amount of RMB 1.436 billion after deducting issuance costs [6]. - The raised funds are managed in a dedicated account, and the company has adhered to relevant regulations regarding the management of these funds [6][7]. Group 3: Implementation and Oversight - The board of directors has authorized the chairman to make investment decisions and sign relevant contracts, with the finance department responsible for implementation [9]. - The company will prioritize using the returns from cash management to supplement any shortfalls in investment amounts for fundraising projects and for daily operational liquidity [10]. Group 4: Regulatory Compliance and Opinions - The cash management plan has been approved by both the board and the supervisory board, complying with relevant regulations and ensuring no change in the purpose of the raised funds [18][21]. - The sponsor, CITIC Securities, has expressed no objections to the cash management plan, confirming that it meets all necessary legal and regulatory requirements [19].
甘李药业: 第五届监事会第二次会议决议公告
Zheng Quan Zhi Xing· 2025-07-21 10:37
Group 1 - The company held its fifth supervisory board's second meeting on July 21, 2025, with a valid resolution passed by the attending supervisors [1] - The supervisory board unanimously approved the proposal to continue using idle raised funds for cash management, allowing up to RMB 250 million for investment in safe and liquid financial products [1] - The investment products include time deposits, structured deposits, and large certificates of deposit, with a usage period not exceeding 12 months from the date of approval [1][2] Group 2 - The board's decision ensures that the use of idle funds will not affect the normal progress of the fundraising investment plan [1] - The voting results showed 3 votes in favor, with no opposition or abstentions [2]
奥泰生物: 关于开立闲置募集资金现金管理专用结算账户的公告
Zheng Quan Zhi Xing· 2025-07-01 16:07
Core Viewpoint - The company has approved the use of temporarily idle raised funds for cash management, allowing a maximum balance of up to RMB 480 million to be invested in high-safety, liquid financial products with a maturity of no more than 12 months [1] Group 1: Cash Management Account - The company has opened a dedicated settlement account for cash management of idle raised funds at CITIC Bank Hangzhou Economic and Technological Development Zone Branch [2] - This account will only be used for cash management of idle raised funds and will not be used for non-raised funds or other purposes [2] Group 2: Investment Risk and Control Measures - The investment is subject to market fluctuations, and actual returns are unpredictable [2] - The company will adhere to relevant regulations and internal management measures to ensure the safety of funds and effective risk control [2][3] Group 3: Impact on Daily Operations - The establishment of the cash management account will not affect the construction of investment projects or normal operations, ensuring the safety of raised funds [3] - Utilizing temporarily idle funds for cash management can enhance the efficiency of fund usage, thereby increasing investment returns and shareholder value [3]